Skip to main content

Possible Dopaminergic Basis for Perceptual Motor Dysfunction

  • Chapter

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 29))

Abstract

There are at least two different forms of intellectual impairment in patients with Parkinson’s disease (PD). Approximately 30% of patients may eventually become demented (1). This dementia is difficult to differentiate from dementia of the Alzheimer type (DAT) (2) and may be associated with similar neuropathologic and neurochemical changes (3,4). In particular, changes in the cholinergic system may be similar (5). The majority of parkinsonians, however, carry on relatively normal lives with unimpaired social and occupational functioning, and meet no recognized criteria for dementia. In these non-demented patients, careful neuropsychological testing often reveals subtle intellectual deficits, most commonly perceptual motor dysfunction (1).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mayeux R, Stern Y. Intellectual dysfunction and dementia in Parkinson’s disease. Adv Neurol 1983; 38: 211–227.

    PubMed  CAS  Google Scholar 

  2. Mayeux R Stern Y, Rosen J, Benson DF. Is “subcortical dementia” a recognizable clinical entity? Ann Neurol 1983;14:278–283.

    Article  CAS  Google Scholar 

  3. Hakim AM and Mathieson G. Dementia Parkinson’s disease: a neuro-pathologic study. Neurology 1979; 29: 1209–14.

    PubMed  CAS  Google Scholar 

  4. Whitehouse P, Hedreen JCr White C, DeLong M, Price DL. Basal forebrain neurons in the dementia of Parkinson’s disease. Ann Neurol 1983; 13: 243–248.

    Article  PubMed  CAS  Google Scholar 

  5. Ruberg M, Ploska A, Javoy-Agid F, Agid Y. Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to dementia. Brain Res 1982; 232: 129–33.

    Article  PubMed  CAS  Google Scholar 

  6. Winblad B, Adolfsson R, Carlsson A Gottfries (DG. Biogenic amines in brains of patients with Alzheimer’s disease. Aging 19; 1982: 25–33.

    CAS  Google Scholar 

  7. Adolfsson R, Gottfries CG, Roos BE, Winblad B: Changes in brain catecholamines in patients with dementia of Alzheimer types. Brit J. Psvchiat. 1979; 135: 216–23.

    Article  CAS  Google Scholar 

  8. Ajuriaguerra J. de, Tissot R. Some aspects of psycho-neurologic disintegration in senile dementia. In: Muller C, Ciompi L (eds.) Senile Dementia. Huber, Switzerland, pp. 69–79.

    Google Scholar 

  9. Joubert M and Barbeau A. Akinesia in parkinson’s disease. In: Barbeau A. and Brunette J-R (eds.) Progress in Neurogenetics. Excerpta Medica, Amsterdam, 1969, pp. 366–376.

    Google Scholar 

  10. Botez MI, Barbeau A. Neuropsychological findings in Parkinson’s disease: A comparison between various tests during long-term levodqpa therapy. Int J Neurol 1975; 10: 222–32.

    PubMed  CAS  Google Scholar 

  11. Stern Y, Mayeux R, Rosen X Ilson J. Perceptual motor dysfunction in Parkinson’s disease: A deficit in sequential and predictive movement. J Neurol Neurosurg Psychiatry 1983; 46: 145–51.

    Article  PubMed  CAS  Google Scholar 

  12. Stern Y, Mayeux R, Rosen J. Contribution of perceptual motor dysfunction and tracing disturbances in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1984; 47: 983–94.

    Article  PubMed  CAS  Google Scholar 

  13. Flowers K. Lack of prediction in the motor behavior of parkinsonism. Brain 1978; 101: 35–52.

    Article  PubMed  CAS  Google Scholar 

  14. Pirozzolo FJ, Hansach EC, Mortimer JA, WëDSter DD and Kuskowski MA. Dementia in Parkinson’s disease: A neuropsychological analysis. Brain cognition 1982; 1: 71–83.

    Article  CAS  Google Scholar 

  15. Mayeux R, Tomaino C, Rosen J, Stern Y, Gerstman L. The effects of parkinsonism and aging on tactile-niotor skills and perception. Neurology (Abstract), 1983; 33: 198A.

    Google Scholar 

  16. Marsden CD: The mysterious irotor function of the basal ganglia: The Robert Wartöiberg Lecture. Neurology 1982; 32: 514–39.

    PubMed  CAS  Google Scholar 

  17. Stern Y. Behavior and the basal ganglia. Adv Neurol 1983; 38: 195–210.

    PubMed  CAS  Google Scholar 

  18. Bowen FP. Behavioral alterations in patients with basal ganglia lesions. In Yahr MD (ed.) The Basal Ganglia. Raven Press, 1975, pp. 169–80.

    Google Scholar 

  19. Lee AJ, Smith E, Cognitive deficits in the early stages of Parkinsons disease. Brain 1983; 106: 257–70.

    Article  Google Scholar 

  20. Lezack M: Neuropsychological assessneit. Oxford Press, New York, 1976, pp. 208–211.

    Google Scholar 

  21. Divac I. Nfeostriatum and functions of the prefrontal cortex. Acta Neurobiol Exp 1972; 32: 461–77.

    CAS  Google Scholar 

  22. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929–32.

    Article  PubMed  CAS  Google Scholar 

  23. Längsten JW, Ballard P, Tefrud JW, Irwin I. Chronic parkinsonism in humans due to a product of mepedrine analogue synthesis. Science 1983; 219: 979–80.

    Article  Google Scholar 

  24. Langstai JW, Ballard P. Parkinsonism induced by l-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP): Implications for treatment arK3 the pathogenesis of Parkinson’s disease. Can J Neurol Sci 1984; 11: 160–5.

    Google Scholar 

  25. Bums RS, Chiveh CC, Markey SP, Ebert MM, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: Selective destruction of neurons in the pars compacta of the substantia ni gra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. Proc Natl Acad Sci. USA, 1983; 80: 4546–50.

    Article  Google Scholar 

  26. Langstai JW, Fomo LS, Robert CS, Irwin I. Selective nigral toxicity after systematic administration of l-inethyl-4-phenyl- 1,2,5,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res. 1984; 292: 390–4.

    Article  Google Scholar 

  27. Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ. Chronic parkinsonism seccxidary to intravenous injection of mg)edrine analogues. Psychiatry Res. 1979; 1: 249–54.

    Article  PubMed  CAS  Google Scholar 

  28. Ballard PA, Längsten JW, Tetrud J. Bums Rs. Chemically induced chronic parkinsonism in young adults: Qinical and neuro- pharmacologic aspects. Neurology (Abstract) 1983; 33: 90A

    Google Scholar 

  29. Stern Y, Langston JW. Intellectual changes in patients with MPTP-induced parkinsonism. Neurology in press.

    Google Scholar 

  30. Matison R, Mayeux R, Rosen J, Fahn S. “Tip-of-the-tongue” phenomenon in Parkinson’s disease. Neurology 1982; 32: 567–70.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Stern, Y., Mayeux, R. (1986). Possible Dopaminergic Basis for Perceptual Motor Dysfunction. In: Fisher, A., Hanin, I., Lachman, C. (eds) Alzheimer’s and Parkinson’s Disease. Advances in Behavioral Biology, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2179-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2179-8_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9283-8

  • Online ISBN: 978-1-4613-2179-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics